Core Insights - Amgen's mission focuses on discovering, developing, manufacturing, and delivering innovative medicines for serious illnesses globally [2] - The company is experiencing strong momentum with a positive long-term growth outlook driven by its diverse therapeutic areas [3] Financial Performance - Amgen reported a 10% revenue growth for the first nine months ending in September, with product sales growing by 11% [4] - The growth was primarily driven by a 14% increase in volume, with 12 products achieving double-digit growth and 14 products annualizing over $1 billion [4] - In the third quarter, 16 products exhibited double-digit growth compared to the previous year, indicating robust business momentum [4] Strategic Outlook - The company is preparing for full-year competition related to its products Prolia and XGEVA, indicating a proactive approach to market challenges [5]